Comorbidity in polymyalgia rheumatica [PDF]
Polymyalgia rheumatica (PMR) is the commonest inflammatory rheumatic disease affecting older people. The current mainstay of treatment is long-term oral glucocorticoid therapy. Management of these patients in clinical practice is often complicated by the
C. Chatzigeorgiou, S.L. Mackie
doaj +8 more sources
Pathogenesis of polymyalgia rheumatica [PDF]
Polymyalgia rheumatica (PMR) is a chronic, inflammatory disorder of unknown cause, almost exclusively occurring in people aged over 50 and often associated with giant cell arteritis.
G. Guggino+4 more
doaj +8 more sources
Physiotherapy for the Management of Polymyalgia Rheumatica: Results From a UK Cross-Sectional Survey. [PDF]
ABSTRACT Introduction Polymyalgia rheumatica (PMR) international management guidelines advocate patient education and individualised exercises but lack evidence and physiotherapy practice for PMR is unknown. PMR is typically treated with glucocorticoids, but side effects are frequent and concerning to patients.
O'Brien AV+4 more
europepmc +2 more sources
Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination [PDF]
Introduction: Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder that causes stiffness and pain in the proximal joints, including the shoulders, hips and neck.
Mohamad El Labban+5 more
doaj +2 more sources
Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature [PDF]
Introduction The aetiology of polymyalgia rheumatica (PMR) is unknown. Recently, reports on cases of PMR following the coronavirus disease 2019 (COVID-19) have revived the role of infection as an aetiological or triggering factor.
Ciro Manzo+2 more
doaj +2 more sources
Polymyalgia rheumatica during the course of limited cutaneous scleroderma: an unusual and challenging coexistence [PDF]
A 50-year-old patient with a history of limited cutaneous scleroderma began with polyarthralgia (left shoulder, elbows and hips) without stiffness or associated inflammatory syndrome.
Noel Lorenzo-Villalba+6 more
doaj +2 more sources
Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review [PDF]
Background To provide evidence-based, up-to-date recommendations for physicians in primary and specialist healthcare setting in diagnosing and treating patients with polymyalgia rheumatica (PMR). Methods The PMR working group conducted a narrative review
Stig Tengesdal+4 more
doaj +2 more sources
Polymyalgia Rheumatica Post-SARS-CoV-2 Infection [PDF]
There is growing evidence that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to dysregulation of the immune system and, consequently, the development of autoimmune phenomena.
Carolina Duarte-Salazar+4 more
doaj +2 more sources
Information on immune checkpoint inhibitor-induced vasculitides is limited, and predictors for this condition have not been identified. Therefore, we have examined the frequency of immune checkpoint inhibitor-induced vasculitides by analyzing the data ...
Koki Kato+6 more
doaj +1 more source
Polymyalgia rheumatica presenting as sternoclavicular arthritis: a case report
Background Polymyalgia rheumatica and giant cell arteritis are systemic inflammatory conditions of the elderly. Polymyalgia rheumatica classically presents as a bilateral proximal muscle pain and stiffness syndrome.
Liyana Arachchige Dona Thulini Madubashini+2 more
doaj +1 more source